These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23359301)

  • 1. IL-6-positive classical Hodgkin's lymphoma co-occurring with plasma cell type of Castleman's disease: report of a case.
    Momoi A; Kojima M; Sakai T; Ajiro J; Isahai N; Nagai K; Aoki S
    Int J Hematol; 2013 Feb; 97(2):275-9. PubMed ID: 23359301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of nodular sclerosis Hodgkin's lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapy.
    Falchi L; Capello D; Palumbo B; Rauco A; Emili R; Cianciulli M; Pace R; Capparella V; Liberati F; Liberati AM
    Eur J Haematol; 2007 Nov; 79(5):455-61. PubMed ID: 17908180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease).
    Abdel-Reheim FA; Koss W; Rappaport ES; Arber DA
    Arch Pathol Lab Med; 1996 Jan; 120(1):91-6. PubMed ID: 8554455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease with coexistent Castleman-like histologic features. A report of three cases.
    Zarate-Osorno A; Medeiros LJ; Danon AD; Neiman RS
    Arch Pathol Lab Med; 1994 Mar; 118(3):270-4. PubMed ID: 8135630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interfollicular Hodgkin's lymphoma and Castleman's disease.
    Zanetto U; Pagani FP; Pérez C
    Histopathology; 2006 Feb; 48(3):317-9. PubMed ID: 16430484
    [No Abstract]   [Full Text] [Related]  

  • 6. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
    Hsu SM; Xie SS; Hsu PL; Waldron JA
    Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
    Nishi J; Maruyama I
    Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular dendritic cell hyperplasia in plasma cell variant of Castleman's disease with interfollicular Hodgkin's disease.
    Vasudev Rao T; Alkindi S; Pathare AV
    Pathol Res Pract; 2007; 203(6):479-84. PubMed ID: 17418501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiofollicular lymph node transformation in Hodgkin's lymphoma.
    Drut R; Larregina A
    Pediatr Pathol; 1991; 11(6):903-8. PubMed ID: 1775404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease presenting with the histological features of Castleman's disease.
    Maheswaran PR; Ramsay AD; Norton AJ; Roche WR
    Histopathology; 1991 Mar; 18(3):249-53. PubMed ID: 1675190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and outcomes in patients with human immunodeficiency virus-negative, Castleman's disease: a single medical center study in Tunisia.
    Chabchoub I; Salah RB; Kallel R; Snoussi M; Frikha F; Marzouk S; Boudawara TS; Bahloul Z
    Rom J Intern Med; 2024 Mar; 62(1):20-32. PubMed ID: 37948573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.
    Lyapichev KA; You MJ; Vega F; Solis LM; Medeiros LJ
    Virchows Arch; 2020 Sep; 477(3):437-444. PubMed ID: 32152665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's and Castleman's disease in a patient with systemic mastocytosis.
    Saletti P; Ghielmini M; Scali G; Pedrinis E; Guéneau M; Cavalli F
    Ann Hematol; 1999 Feb; 78(2):97-100. PubMed ID: 10089028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of multicentric Castleman's disease demonstrating severe eosinophilia and enhanced production of interleukin-5.
    Ishii T; Tatekawa T; Koseto M; Ishii M; Kobayashi H; Koike M; Fujii T; Saeki Y
    Eur J Haematol; 2003 Feb; 70(2):115-8. PubMed ID: 12581193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific infiltrate of Hodgkin lymphoma at site of cellulitis mimicking secondary cutaneous involvement.
    Facheris P; Valenti M; Pavia G; Grizzi F; Narcisi A; Costanzo A; Borroni RG
    J Cutan Pathol; 2020 May; 47(5):462-465. PubMed ID: 31769877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three patients with both Hodgkin's lymphoma and Castleman's disease: Clinicopathologic correlations and lack of association with HHV-8.
    Haque S; van Kirk R
    Indian J Med Paediatr Oncol; 2009 Apr; 30(2):76-9. PubMed ID: 20596307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Large B-cell lymphoma coexisting with Castleman's disease. Report of one case].
    Avilés-Salas A; Candelaria M; Sevilla-Lizcano DB; Burgos S
    Rev Med Chil; 2017 Jul; 145(7):945-949. PubMed ID: 29182205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of interleukin-6 in Castleman's disease.
    Hsu SM; Waldron JA; Xie SS; Barlogie B
    Hum Pathol; 1993 Aug; 24(8):833-9. PubMed ID: 8375854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interfollicular Hodgkin's disease: an uncommon pattern that may cause diagnostic difficulty.
    Basu D; Roy SK
    Indian J Pathol Microbiol; 2006 Apr; 49(2):221-5. PubMed ID: 16933719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of Hodgkin's Lymphoma and Castleman's Disease: A Case Report with Successful Response to Chemotherapy and Radiotherapy.
    Mohtaram A; Afif M; Sghiri T; Rami A; Latib R; Kettani F; Ben Ameur El Youbi M; Boutayeb S; Kebdani T; Benjaafar N; Aaribi I; Errihani H
    Case Rep Oncol Med; 2013; 2013():487205. PubMed ID: 24381772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.